Anna Flender
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Inflammasome and immune disorders
Papers in
-
- Extracellular vesicles in disease 5
- Inflammasome and immune disorders 3
-
- interferon and immune responses 1
- Atherosclerosis and Cardiovascular Diseases 1
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 1
- Immune Response and Inflammation 1
- Co-authors
- Georg Nickenig (9 shared papers)Felix Jansen (7 shared papers)Theresa Schmitz (7 shared papers)Nikos Werner (6 shared papers)Xiaoyan Yang (2 shared papers)Bernardo S. Franklin (2 shared papers)Philipp Pfeifer (2 shared papers)Andreas Zietzer (3 shared papers)
- Journals
- Journal of Molecular and Cellular Cardiology (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Circulation Research (1 paper)Journal of the American Heart Association (1 paper)Frontiers in Cardiovascular Medicine (1 paper)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Anna Flender
9 papers receiving 585 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 283
- Molecular Biology 425
- Cardiology and Cardiovascular Medicine 116
- Immunology 108
- Aging 5
Countries citing papers authored by Anna Flender
This map shows the geographic impact of Anna Flender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Flender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Flender more than expected).
Fields of papers citing papers by Anna Flender
This network shows the impact of papers produced by Anna Flender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Flender. The network helps show where Anna Flender may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Flender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 147 | |
| 2 | 2016 | 116 | |
| 3 | 2015 | 113 | |
| 4 | 2017 | 112 | |
| 5 | 2017 | 30 | |
| 6 | 2020 | 23 | |
| 7 | 2017 | 20 | |
| 8 | 2016 | 19 | |
| 9 | 2020 | 11 |
About Anna Flender
Anna Flender is a scholar working on Molecular Biology, Immunology, Cancer Research, Rheumatology and Infectious Diseases, having authored 9 papers that have together received 591 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), Inflammasome and immune disorders (3 papers), MicroRNA in disease regulation (2 papers), interferon and immune responses (1 paper), Atherosclerosis and Cardiovascular Diseases (1 paper), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Immune Response and Inflammation (1 paper) and Cancer-related molecular mechanisms research (1 paper). The work is most often cited by research in Cancer Research (283 citations), Molecular Biology (425 citations), Cardiology and Cardiovascular Medicine (116 citations), Immunology (108 citations) and Aging (5 citations). Anna Flender has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Georg Nickenig, Felix Jansen, Theresa Schmitz, Nikos Werner, Xiaoyan Yang, Bernardo S. Franklin, Philipp Pfeifer, Andreas Zietzer, Han Wang and Philip Roger Goody. Their work appears in journals such as Journal of Molecular and Cellular Cardiology, Journal of Cellular and Molecular Medicine, Circulation Research, Journal of the American Heart Association and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.